← FDA DRUG APPROVALS

FDA NDA · NDA006800

PARADIONE

Sponsor: ABBVIE

APPLICATION
NDA006800
TYPE
NDA
ORIGINAL APPROVAL
1949-06-15
LATEST ACTION
1989-03-24
ROUTE
ORAL
DOSAGE FORM
SOLUTION, CAPSULE
MARKETING STATUS
Discontinued

Products

PARADIONEDiscontinued
PARAMETHADIONE 300MG/ML · SOLUTION · ORAL
PARADIONEDiscontinued
PARAMETHADIONE 150MG · CAPSULE · ORAL
PARADIONEDiscontinued
PARAMETHADIONE 300MG · CAPSULE · ORAL

Approval history

1989-03-24Manufacturing (CMC) · Supplement 15AP
1987-12-02Manufacturing (CMC) · Supplement 14AP
1984-12-07Manufacturing (CMC) · Supplement 13AP
1982-06-28Manufacturing (CMC) · Supplement 12AP
1980-07-14Labeling · Supplement 10AP
1979-10-24Manufacturing (CMC) · Supplement 8AP
1975-07-29Manufacturing (CMC) · Supplement 5AP
1949-06-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →